Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol.

Kristi R GriffithsJenny YangStephen W TouyzPhillipa J HaySimon D ClarkeMayuresh S KorgaonkarLinette GomesGail AndersonSheryl FosterMichael R Kohn

Published in: Journal of eating disorders (2019)

ACTRN12618000623291, Australian and New Zealand Clinical Trials Registry URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374913&isReview=true. Date of Registration: 20 April 2018.

Keyphrases

clinical trial
study protocol
phase ii
phase iii
randomized controlled trial
open label
double blind
sensitive detection
smoking cessation
reduced graphene oxide
visible light